Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
empagliflozin cancer | 1.34 | 0.6 | 648 | 33 | 20 |
empagliflozin | 0.83 | 0.5 | 8884 | 24 | 13 |
cancer | 1.4 | 0.1 | 968 | 88 | 6 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
empagliflozin canada | 1.62 | 1 | 4787 | 50 |
empagliflozin candida | 0.16 | 0.9 | 768 | 22 |
empagliflozin canagliflozin | 0.45 | 0.8 | 255 | 99 |
empagliflozin contraindications | 1.5 | 1 | 7219 | 72 |
empagliflozin and bladder cancer risk | 1.75 | 0.3 | 1422 | 15 |
empagliflozin thyroid cancer | 0.38 | 0.8 | 5810 | 33 |
empagliflozin and bladder cancer | 1.77 | 0.2 | 1951 | 60 |
empagliflozin bladder cancer | 0.94 | 0.2 | 3740 | 46 |
empagliflozin and pancreatic cancer | 1.29 | 0.4 | 8528 | 6 |
empagliflozin pancreatitis | 1.61 | 0.8 | 5934 | 47 |
empagliflozin canagliflozin and dapagliflozin | 0.1 | 0.1 | 3514 | 55 |
empagliflozin pancreatic cancer | 1.82 | 0.2 | 6420 | 87 |
empagliflozin pancreas | 0.52 | 1 | 3607 | 44 |
empagliflozin controlled substance | 1.16 | 0.6 | 5308 | 16 |
empagliflozin cardiovascular outcomes | 0.55 | 0.3 | 4414 | 17 |
empagliflozin cardiac | 0.39 | 0.6 | 377 | 15 |
empagliflozin cardiac benefit | 0.88 | 0.4 | 8815 | 41 |
empagliflozin cardiovascular benefit | 0.11 | 0.9 | 2942 | 92 |
empagliflozin cardiovascular | 0.23 | 0.9 | 7560 | 59 |
empagliflozin brand name canada | 0.9 | 0.1 | 9106 | 99 |
empagliflozin cost canada | 1.26 | 0.6 | 9660 | 56 |
empagliflozin product monograph canada | 0.12 | 0.9 | 6671 | 40 |